India's IT Rules 2026 mandate 3-hour deepfake removal, SGI labelling, and 2-hour non-consensual content takedown.

India's AI Pipeline: 43% Women STEM Graduates, Only 10% in Leadership – Need for Inclusive AI

India's AI ambition faces a hidden gender crisis: women drop from 43% of STEM graduates to just 10% of senior AI leadership. This pipeline leakage, driven by social barriers and digital divide, risks automating existing inequalities. For exam aspirants, this article provides critical data on gender disparity in tech and the imperative for inclusive AI development.

India Ranks 3rd in Research Volume, 19th in h-index; NIRF's 30% Weightage Under Scrutiny

India’s research output is booming on paper—1.6 million Scopus-indexed papers in five years and a 4x jump in university patent filings—but global impact is weak: India ranks only 19th by h-index and 3rd in retractions. The article exposes how NIRF’s 30% weightage to raw research output and a cash-incentive culture have created a ‘paper fortress’ rather than real-world knowledge power.

MeitY Summons Meta Global Team Over Algorithmic Bias; Parliamentary Panel to Question

Government summons Meta's global team to clarify algorithmic bias and role in public order after MeitY rejects technical glitch explanation. Parliamentary panel will also question the company. This highlights growing regulatory scrutiny on social media algorithms and their societal impact.

NOTTO Reports 20,000+ Transplants in 2025, Launches Portal and Swap Guidelines

NOTTO released 2025 data showing over 20,000 transplants, persistent gender disparity in organ donation (68% female donors vs 78% male recipients), and launched a new digital portal to enhance transparency. New swap transplantation guidelines aim to expand matching beyond single hospitals, but legal recognition under THOTA is still pending.

Health Ministry Amends Drugs Rules, 1945: New Debarment Power for Fake Data Cases

The Health Ministry has strengthened the Drugs Rules, 1945 to penalize applicants who submit fake data for drug approvals. Previously, only rejection/cancellation was possible; now licensing authorities can debar entities from filing new applications for a period, with show-cause notice and appeal provisions. This is crucial for exam questions on regulatory frameworks, pharmaceutical governance, and the Drugs & Cosmetics Act.

Meta Trial: $567 Mn Penalty for Child Addiction, 29-State Probe on Social Media Design

A US trial against Meta over addictive social media design for children could reshape Big Tech accountability. With penalties of $567 million and a $6 million jury verdict, this case highlights the growing scrutiny of platform design and its impact on youth mental health, a key issue for GS2 (Social Justice) and GS3 (Technology).

VP Launches India Valve Registry for Heart Valve Disease Research; TN Reports 2,590 Valve Replacements in 20 Months

The Vice-President launched the India Valve Registry, a first-of-its-kind clinician-led platform to collect real-world data on valvular heart disease and interventions in India. The registry will generate India-specific evidence to improve patient care, while Tamil Nadu's CMCHIS data reveals 2,590 valve replacements in 20 months, highlighting the burden of rheumatic heart disease and the success of state-led healthcare.

FSSAI Initiates 3 Cases Against Nestlé India Over IMS Act, Biotin Levels

FSSAI has initiated three separate cases against Nestlé India for alleged violations of the IMS Act and food safety regulations related to infant formula promotional claims and biotin content. This action reinforces India's strict stance on protecting breastfeeding practices and regulating infant nutrition marketing. For exams, this links to the FSS Act, IMS Act, and regulatory enforcement mechanisms.